EGFR and glioblastoma: We showed that HELDR promotes EGFR-driven GBM tumorigenesis by inducing genes in oncogenic pathways critical for GBM malignancy via binding to and recruiting p300 to KAT7 gene promoter independent of EGFR expression and signaling.